Global Osteoporosis Market Synopsis:

The Global “Osteoporosis Market” research 2019 highlights the major details and provides in-depth analysis of the market along with the future growth, prospects and Industry demands analysis explores with the help of complete report with 50 Pages, figures, graphs and table of contents to analyze the situations of global Osteoporosis Market and Assessment to 2023.

This report studies the Global Osteoporosis Market over the forecast period of 2019 to 2023. The Global Osteoporosis Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2019 to 2023.

Get Sample Study Papers of “Global Osteoporosis Market” @ https://www.businessindustryreports.com/sample-request/162973 .

Osteoporosis develops due to increasing pores in the bones. As the density in the bones increasesIt makes the bones weaker and breakable. Thus increasing the risk of fractures, mainly in wrist, hip, and spinal vertebrae. The development of bone tissues continues until late 30’s and then starts reducing rapidly. If it reduces rapidly, it results in osteoporosis. Osteoporosis is largely seen among females as compared to males, mainly after menopause that decreasing estrogen in the body.

The company’s latest report states that this relatively modest growth will mainly be driven by the significant rise in the prevalence of this disorder globally. This unprecedented rise in the prevalence resulted in the high demand for drugs in prophylaxis and treatment of osteoporosis thus widening the growth potential over the coming years. Moreover, the geriatric population possessing high susceptibility for osteoporosis is further presumed to propel the high demand.

Osteoporosis MarketCovers the Table of Contents With Segments, Key Players And Region. Based on drug type, Osteoporosis Market is sub segmented into bisphosphonates, parathyroid hormone therapy, calcitonin, selective estrogen inhibitors modulator (SERM) and rank ligand inhibitors. Bisphosphonates is extensively used for prevention and treatment of osteoporosis, thus dominating the osteoporosis treatment market.

Geographically, North America is the leading the global osteoporosis market, mainly due to increased number suffering from osteoporosis. Technological advancements and increasing awareness about the disease have also grown in this region. Increasing population in the Asia Pacific will also boost the demand for osteoporosis market in the forecast period.

MajorPlayers profiled in the Osteoporosis Marketreport incorporate: Aegis therapeutics, Amgen, Bone medical, Chugai pharmaceutical, Eli lilly, Merck & co., Novartis pharma, Novo nordisk, Ranbaxy laboratories and Osteologix.

Latest Industry News

1 Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) today announced that the U.S. Food and Drug Administration (FDA) has approved EVENITY™ (romosozumab-aqqg) for the treatment of osteoporosis in postmenopausal women at high risk for fracture. EVENITY is the first and only bone builder with a unique dual effect that both increases bone formation and to a lesser extent reduces bone resorption (or bone loss) to rapidly reduce the risk of fracture. A full course of EVENITY therapy is 12 monthly doses administered by a healthcare provider.2 Since osteoporosis is a chronic disease, continued therapy with an anti-resorptive agent should be considered once EVENITY therapy is completed.

MS neurologists in the United States, Canada, and Germany tested the tool with 198 patients with a diagnosis of RRMS, SPMS or a suspected transition to SPMS. In the validation study, physicians went through a series of weighted questions with the patients based on their experience in the last six months. The questions aim to gather information on symptoms and how they impact daily life and activities. Once completed, the algorithm generated a visual output that the physicians could use to facilitate a discussion around the level of disease progression. The results from the validation study demonstrated that MSProDiscussTM was able to differentiate between RRMS and SPMS patients with high sensitivity and specificity and thus also inform about patients in transition.

One in two women will experience a fracture due to osteoporosis in her lifetime.1 These fractures can be devastating, with many leading to hospital stays and life-altering consequences.3 The FDA approval of EVENITY represents an important therapeutic development for patients who need a medicine that can rapidly increase bone mineral density and help reduce the risk of future fractures within 12 months," said David M. Reese, M.D., executive vice president of Research and Development at Amgen.

Purchase this report online with 50 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Osteoporosis Market Report 2019” @ https://www.businessindustryreports.com/buy-now/162973/single .

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Osteoporosis in these regions, from 2014 to 2023 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America.

Significant points in table of contents: Market Definition, Market Overview, Business Introduction, Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation (Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost Analysis, and Conclusion.

Report contents include

1 Analysis of the OsteoporosisMarket including revenues, future growth, market outlook

2 Historical data and forecast

3 Regional analysis including growth estimates

4 Analyzes the end user markets including growth estimates.

5 Profiles on Osteoporosisincluding products, sales/revenues, and market position

6 Market structure, market drivers and restraints.

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

[email protected]

+19376349940